Dess Glass

Des Glass

Executive Vice President & Chief Financial Officer

Executive Leader
About

Des Glass is Executive Vice President and Chief Financial Officer, bringing over two decades of senior financial leadership across multinational, publicly listed, and high‑growth organizations. He joined Quotient Sciences in April 2022, applying deep expertise in strategic financial management, capital optimisation, and operational alignment, along with significant experience scaling international companies and driving financial performance.

Before joining Quotient Sciences, Des served as Group CFO at RWS Holdings plc, the world’s leading provider of technology localisation and language services, where he helped accelerate global expansion through strategic acquisitions and operational transformation. Previously, he spent nine years as CFO of GAN plc, where he helped guide the business from a fast‑moving technology start‑up to a successful AIM flotation and expanded its operations across the US and Europe. His earlier career included senior finance roles at Rodale, Primedia, and ABC in New York, strengthening his leadership experience across media and technology‑driven businesses across international markets.

Des began his career at Deloitte, is a Fellow of the Institute of Chartered Accountants in Ireland, and holds an MBA from Imperial College London.

Group of scientists in laboratory
Translational Pharmaceutics, Clinical Pharmacology, Drug Product

Corporate Overview Info Sheet

10 March 2025 Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Artificial Intelligence Andy Lewis on AI‑Enabled Formulation Design and Faster Speed to Clinic By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Early Drug Development, Artificial Intelligence AI's Role in Fast-tracking Early Drug Development; Our ground breaking alliance with Intrepid Labs By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Artificial Intelligence Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs By: Andy Lewis
Read More